pyrazines has been researched along with 6-ketoprostaglandin f1 alpha in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (78.95) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, LH; Duan, SF; Peng, W | 1 |
| Li, B | 1 |
| Edlund, A; Musatti, L; Wennmalm, A | 1 |
| Gu, MJ; Liu, ZM | 1 |
| Wang, XP; Xu, JY; Yuan, YZ | 1 |
| Guo, ZQ; Liao, JZ; Wang, SR | 1 |
| Fu, CJ; Zhang, JF; Zhao, GS | 1 |
| Duan, SF; Peng, W | 1 |
| Feng, J; Liu, R; Tang, S; Wu, G | 2 |
| Chen, X; Demura, H; Jin, Z; Liu, H; Naruse, M; Pan, J; Shi, Y; Zeng, Z; Zhou, X; Zhu, W | 1 |
| Chen, SX; Wang, LX; Xing, LL | 1 |
| Chen, D; Huang, R; Liao, C | 1 |
| Ma, T; Wen, L; Xu, J | 1 |
| Ma, D; Wang, S; Xin, K | 1 |
| Dong, H; Tang, R; Tong, J; Wang, Y; Xu, J | 1 |
| Hu, Z; Lin, LN; Wang, WT; Wu, JZ; Xie, K | 1 |
| Combs, K; Daunert, S; Deo, S; Ensor, C; Qu, X; Rowe, L | 1 |
| Islam, MS; Jisaka, M; Khan, F; Nartey, MN; Nishimura, K; Rahman, MS; Shono, F; Syeda, PK; Yokota, K | 1 |
4 trial(s) available for pyrazines and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Acipimox stimulates skin blood flow by a cyclo-oxygenase-dependent mechanism.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cyclooxygenase Inhibitors; Female; Hemodynamics; Humans; Hypolipidemic Agents; Male; Pyrazines; Regional Blood Flow; Skin; Skin Temperature | 1990 |
[Effects of tetramethylpyrazine on platelet functions of advanced cases of lung carcinoma].
Topics: 6-Ketoprostaglandin F1 alpha; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Thromboxane B2 | 1997 |
[Effects in tetramethylpyrazine on TXA2 and PGI2 by cardio-pulmonary bypass in congenital heart diseases with pulmonary hypertension patients].
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Cardiopulmonary Bypass; Child; Child, Preschool; Female; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Male; Pyrazines; Thromboxane B2; Vasodilator Agents | 1998 |
[Protective effect of ligustrazine and propofol on peri-operational liver ischemia-reperfusion injury].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Drug Therapy, Combination; Female; Humans; Lipid Peroxides; Liver; Liver Neoplasms; Male; Middle Aged; Propofol; Pyrazines; Reperfusion Injury; Superoxide Dismutase | 2006 |
15 other study(ies) available for pyrazines and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Effects of sustained ligustrazine on hemorrheology in patients with chronic pulmonary heart disease.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aged, 80 and over; Blood Viscosity; Female; Fibrinolytic Agents; Heart Failure; Hematocrit; Humans; Male; Middle Aged; Pulmonary Heart Disease; Pyrazines; Thromboxane B2 | 1992 |
[The observation of changes in plasma PGI2 and TXA2 levels and the therapeutic effect of tetramethylpyrazine in E. coli induced acute lung injury in rabbits].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Escherichia coli Infections; Lung; Lung Diseases; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Rabbits; Thromboxane B2 | 1991 |
[Prevention of toxicity of cyclosporine A on rat pancreatic islet beta-cells by Ligustrazine].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cyclosporine; Fibrinolytic Agents; Islets of Langerhans; Male; Pyrazines; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 1993 |
[Therapeutic effects and mechanisms of tetramethylpyrazine on lung injury in acute haemorrhagic necrotizing pancreatitis in rats].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Free Radical Scavengers; Lipid Peroxides; Lung; Necrosis; Pancreatitis; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 1993 |
[Experimental study on effects of 18 kinds of Chinese herbal medicine for synthesis of thromboxane A2 and PGI2].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Lung; Microsomes; Phenanthrolines; Plant Extracts; Pyrazines; Salvia miltiorrhiza; Saponins; Swine; Thromboxane B2 | 1993 |
[Effect of ligustrazine on isolated myocardial ischemic reperfusion injury in rats].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Female; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardial Reperfusion Injury; Pyrazines; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 1993 |
[Effect of ligustrazine controlled release capsule on hemorrheology in patients with cor pulmonale].
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Blood Viscosity; Delayed-Action Preparations; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Pulmonary Heart Disease; Pyrazines; Thromboxane B2 | 1993 |
Pretreatment with tetramethylpyrazine increases the release of PGI2 and decreases TXA2 release in isolated rat heart.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Heart; In Vitro Techniques; Male; Myocardium; Pyrazines; Rats; Rats, Sprague-Dawley; Reference Values; Thromboxane A2; Vasodilator Agents | 1996 |
Effects of tetramethylpyrazine on the release of PGI2 and TXA2 in the hypoxic isolated rat heart.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Coronary Circulation; Epoprostenol; Heart; Hypoxia; In Vitro Techniques; Male; Myocardium; Perfusion; Platelet Aggregation Inhibitors; Pyrazines; Rats; Rats, Sprague-Dawley; Thromboxane A2; Thromboxane B2; Time Factors; Vasodilator Agents | 1997 |
Tetramethylpyrazine, a Chinese drug, blocks coronary vasoconstriction by endothelin-1 and decreases plasma endothelin-1 levels in experimental animals.
Topics: 6-Ketoprostaglandin F1 alpha; Angiography; Animals; Coronary Vessels; Dogs; Drugs, Chinese Herbal; Electrocardiography; Endothelin-1; Male; Pyrazines; Rabbits; Vasoconstriction; Vasodilator Agents | 1998 |
[Study on relativity between oxygen free radical and thromboxane B2, 6-keto-PGF1 alpha during ligustrazine treatment of intrauterine growth retardation].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Female; Fetal Growth Retardation; Free Radical Scavengers; Humans; Pregnancy; Pyrazines; Superoxide Dismutase; Thromboxane B2 | 1998 |
[Effects of ligustrazine on plasma platelet aggregation rate, thromboxane B2, 6-keto-prostaglandin F1 alpha and von Willebrand's factor in patients with acute onset of cor pulmonale].
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Heart Disease; Pyrazines; Qi; Thromboxane B2; von Willebrand Factor | 1999 |
Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Female; Fluorescent Antibody Technique, Direct; Glomerular Basement Membrane; Glomerulonephritis; Immunoglobulin G; Kidney Glomerulus; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Proteinuria; Pyrazines; Rats; RNA, Messenger; Thromboxane A2 | 2004 |
Genetically modified semisynthetic bioluminescent photoprotein variants: simultaneous dual-analyte assay in a single well employing time resolution of decay kinetics.
Topics: 6-Ketoprostaglandin F1 alpha; Aequorin; Angiotensin II; Animals; Escherichia coli; Half-Life; Imidazoles; Immunoassay; Kinetics; Mutation; Protein Engineering; Pyrazines | 2008 |
Pretreatment of cultured preadipocytes with arachidonic acid during the differentiation phase without a cAMP-elevating agent enhances fat storage after the maturation phase.
Topics: 1-Methyl-3-isobutylxanthine; 3T3-L1 Cells; 6-Ketoprostaglandin F1 alpha; Acetates; Adipocytes; Adipogenesis; Animals; Arachidonic Acid; Cell Differentiation; Cells, Cultured; Cyclic AMP; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Gene Expression Regulation; Humans; Hydroxyprostaglandin Dehydrogenases; Membrane Proteins; Mesenchymal Stem Cells; Mice; Prostaglandin-E Synthases; Pyrazines; Receptors, Prostaglandin; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Triglycerides | 2016 |